Tech Journal of Colorado: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on September 5, 2025

September 5, 2025

Revive Therapeutics Announces Extension of Proposed Private Placement

GlobeNewswire

September 5, 2025

Altai Provides Update on Quebec Litigation

GlobeNewswire

September 5, 2025

Enovix Announces Completion of Warrant Dividend Program

GlobeNewswire

September 5, 2025

Rackspace Technology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

September 5, 2025

NetDragon Showcases AI-Powered Education Solutions at UNESCO Digital Learning Week 2025

GlobeNewswire

September 5, 2025

United Flow Technologies acquires Sydnor Hydro, expanding Mid-Atlantic pumping solutions expertise

GlobeNewswire

September 5, 2025

DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq

GlobeNewswire

September 5, 2025

DBV Technologies met en place un Programme At-The-Market (ATM) sur le Nasdaq

GlobeNewswire

September 5, 2025

DIH Holding US, Inc. Receives Nasdaq Staff Determination Letter

GlobeNewswire

September 5, 2025

dLocal Announces Closing of Secondary Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

September 5, 2025

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

September 5, 2025

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

September 5, 2025

Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025

GlobeNewswire

September 5, 2025

Artelo Biosciences Announces Closing of $3.0 Million Public Offering

GlobeNewswire

September 5, 2025

Gyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

GlobeNewswire

September 5, 2025

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

September 5, 2025

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

September 5, 2025

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

September 5, 2025

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

September 5, 2025

DIAGNOS Announces Closing of Private Placement

GlobeNewswire